Edessy Stem Cell Score (ESS), Endometrium, Endometrioma
- Conditions
- Endometriosis, Ovarian
- Interventions
- Procedure: Ovarian and endometrial samples
- Registration Number
- NCT02103452
- Lead Sponsor
- Al-Azhar University
- Brief Summary
Purpose of this study is to evaluate stem cell expression (SCE) in endometriotic (E) and non endometriotic ovarian and endometrial tissues.
- Detailed Description
This study was conducted on 40 women at Al-Azhar University Hospitals. They are divided into two equal groups, group 1 with ovarian endometrioma and group 2 with normal ovary. Ovarian and endometrial samples were evaluated by hematoxlin \& eosin for histopathology (HP) and of oct-4 for immunohistochemistry (IH) for SCE.
Evaluation of IH parameters revealed that the most important factors for evaluating SC were arranged as score ( Edessy Stem Cell Score=ESS).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 80
- 20 to 40 years and did not receive hormonal treatment for three month
- Diabetes mellitus, cardiovascular and kidney diseases, adenomyosis, Uterine fibroid Endometrial carcinoma and Poly cystic ovary
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description ovarian endometrioma Ovarian and endometrial samples Ovarian and endometrial samples normal ovary Ovarian and endometrial samples Ovarian and endometrial samples
- Primary Outcome Measures
Name Time Method Edessy Stem Cell Score (ESS) 1 week ESS
* Intensity of stem cell marker: Negative to mild =0, Moderate =1, Strong =2
* Percentage of stained cells: 0 =0, 0-50%= 1, \>50-100% =2.
* Focality : None =0, Focal =1, Diffuse= 2
* Distribution: None= 0, Epithelial or mesenchymal= 1, Epithelial and mesenchymal= 2.
* Localization of positive stained cell: None=0, Cytoplasmic or nuclear =1, Cytoplasmic and nuclear= 2
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Al Azhar University
🇪🇬Cairo, Egypt